Organisation paid for research Program year 2025 Source: CMS Open Payments

Nephrology Consultants

Neither a doctor nor a teaching hospital

Research payments

$801,708

94 payments

Through program year 2025, Nephrology Consultants is reported as receiving $801,708 in research payments, across 94 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$798	8
2024	Research	$15,204	3
2023	Research	$15,195	3
2022	Research	$123,867	8
2021	Research	$212,521	23
2020	Research	$393,415	19
2019	Research	$40,709	30

Breakdown

Who paid Research payments · program years 2019–2025

Boehringer Ingelheim International GmbH $360,021 41 payments
Boehringer Ingelheim Pharma GmbH & Co.KG $315,459 44 payments
Boehringer Ingelheim Pharmaceuticals, Inc. $93,608 8 payments
Merck Sharp & Dohme Corporation $32,621 1 payment

Studies the money was for Research payments · program years 2019–2025

Empa-Kidney $535,897 41 payments
Empa Kidney $122,576 3 payments
MRD for BI 685509 in DN Patients $91,327 31 payments
A Randomized Parallel-group, Placebo-controlled, Double-blind, Event-driven, Multi-center Phase 2 Clinical Outcome Trial of Prevention of Arteriovenous Graft Thrombosis and Safety of MK-2060 in Participants with End Stage Renal Disease Receiving Hemodialysis. $32,621 1 payment
Slope Estimation and Homogeneity Study $9,625 2 payments
PoCP study in FSGS $8,865 8 payments
A simultaneous vs. staggered initiation study of BI 690517 and empagliflozin for SGLT2i treatment-naive participants with CKD $798 8 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.